Phase II Clinical Study on Children and Adolescents/Young Adults with Clear Cell Sarcoma of the Kidney

Phase II Clinical Study on Children and Adolescents/Young Adults with Clear Cell Sarcoma of the Kidney - Phase II Clinical Study on Children and Adolescents/Young Adults with Clear Cell Sarcoma of the Kidney

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028428

Enrollment

Registered

2017-08-10

Start date

2017-07-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clear cell sarcoma of the kidney (CCSK)

Interventions

Surgery, chemotherapy, irradiation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Stage I-IV (unilateral) All patients and/or their legal guardians must sign a written informed consent. ECOG Performance Status: 3 or less (better). No prior therapy of anti-cancer drugs and irradiation with the exception of what was written in protocol.

Exclusion criteria

Exclusion criteria: Relapsed CCSK Double cancer within 5 years Organ dysfunction Positive pregnancy test Female patients who are lactating Others written in the protocol

Design outcomes

Primary

Measure	Time frame
Stage I, II, III: progression-free survival. Stage IV: treatment completion.	—

Countries

Japan

Contacts

Public ContactTsugumichi KOSHINAGA

Nihon University School of Medicine Department of Pediatric Surgery

koshinaga.tsugumichi@nihon-u.ac.jp03-3972-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026